ResMed Inc. (RMD)

Price$186.44

Value ScoreB

Growth ScoreB

Momentum ScoreD

Favorite Metrics

Price vs S&P 500 (26W)-37.80%

Price vs S&P 500 (4W)-12.02%

VGM Score50.27

Market Capitalization$27.41B

P/E Ratio (Annual)19.57x

Indicated Dividend Yield (Annual)1.26%

All Metrics

P/CF (Annual)15.65x

Book Value / Share (Quarterly)$44.76

P/TBV (Annual)6.87x

Indicated Dividend (Annual)$2.40

Revenue Growth (3Y)12.88%

Cash Flow / Share (Quarterly)$11.97

Payout Ratio (TTM)22.39%

Price vs S&P 500 (YTD)-31.82%

Gross Margin (TTM)61.56%

Net Profit Margin (TTM)27.44%

EPS (TTM)$10.37

10-Day Avg Trading Volume1.60M

EPS Excl Extra (TTM)$10.37

Revenue Growth (5Y)11.72%

EPS (Annual)$9.51

Dividend / Share (Annual)$2.12

ROI (Annual)21.11%

Gross Margin (Annual)59.33%

Net Profit Margin (5Y Avg)21.38%

Cash / Share (Quarterly)$11.45

P/E Basic Excl Extra (TTM)18.04x

Revenue Growth QoQ (YoY)10.81%

EPS Growth (5Y)17.38%

P/E Normalized (Annual)19.57x

ROA (Last FY)17.14%

Revenue Growth TTM (YoY)10.28%

EBITD / Share (TTM)$13.24

ROE (5Y Avg)21.16%

Operating Margin (TTM)34.18%

Cash Flow / Share (Annual)$11.28

P/B Ratio4.22x

P/B Ratio (Quarterly)5.04x

Net Income / Employee (Annual)$132,100

EV / Revenue (TTM)4.77x

Net Interest Coverage (TTM)661.20x

ROA (TTM)18.00%

EPS Growth QoQ (YoY)10.35%

EV / EBITDA (TTM)13.62x

EPS Incl Extra (Annual)$9.51

Current Ratio (Annual)3.44x

Quick Ratio (Quarterly)2.00x

3-Month Avg Trading Volume1.23M

52-Week Price Return-22.25%

EV / Free Cash Flow (Annual)16.00x

P/E Incl Extra (TTM)18.04x

Revenue / Employee (TTM)$522,400

Tangible BV / Share (Quarterly)$41.83

P/S Ratio (Annual)5.33x

Asset Turnover (Annual)0.63x

52-Week High$293.81

Operating Margin (5Y Avg)28.89%

EPS Excl Extra (Annual)$9.51

CapEx CAGR (5Y)-1.01%

Tangible BV CAGR (5Y)21.85%

26-Week Price Return-21.87%

Quick Ratio (Annual)2.16x

13-Week Price Return-25.87%

Total Debt / Equity (Annual)0.11x

Current Ratio (Quarterly)3.01x

Enterprise Value$26.41B

Revenue / Share Growth (5Y)11.47%

Asset Turnover (TTM)0.66x

Book Value / Share Growth (5Y)18.79%

Revenue / Employee (Annual)$485,500

Inventory Turnover (Annual)2.39x

Pretax Margin (Annual)32.60%

Cash / Share (Annual)$8.26

3-Month Return Std Dev25.41%

Gross Margin (5Y Avg)57.21%

Net Income / Employee (TTM)$143,400

EBITDA CAGR (5Y)15.97%

EBITDA Interim CAGR (5Y)17.23%

ROE (Last FY)23.47%

Net Interest Coverage (Annual)58.23x

EPS Basic Excl Extra (Annual)$9.51

P/FCF (TTM)15.79x

Receivables Turnover (TTM)5.52x

EV / Free Cash Flow (TTM)15.21x

Total Debt / Equity (Quarterly)0.10x

EPS Incl Extra (TTM)$10.37

Receivables Turnover (Annual)5.52x

ROI (TTM)22.05%

Dividend Growth Rate (5Y)6.33%

P/S Ratio (TTM)4.95x

Pretax Margin (5Y Avg)28.03%

Revenue / Share (Annual)$34.93

Tangible BV / Share (Annual)$37.59

Forward P/E15.83x

Free OCF CAGR (5Y)18.84%

Price vs S&P 500 (52W)-50.46%

P/E Ratio (TTM)18.04x

EPS Growth TTM (YoY)16.47%

Year-to-Date Return-20.88%

5-Day Price Return-8.40%

EPS Normalized (Annual)$9.51

ROA (5Y Avg)14.13%

Net Profit Margin (Annual)27.22%

Month-to-Date Return-10.87%

Cash Flow / Share (TTM)$7.33

EBITD / Share (Annual)$11.75

EPS Growth (3Y)21.50%

Operating Margin (Annual)32.75%

LT Debt / Equity (Annual)0.11x

P/CF (TTM)14.50x

ROI (5Y Avg)17.56%

P/E Excl Extra (TTM)18.04x

LT Debt / Equity (Quarterly)0.06x

EPS Basic Excl Extra (TTM)$10.37

P/TBV (Quarterly)5.39x

Payout Ratio (Annual)22.19%

P/B Ratio (Annual)6.34x

Dividend / Share (TTM)$2.33

Inventory Turnover (TTM)2.40x

Pretax Margin (TTM)34.37%

Book Value / Share (Annual)$40.77

Price vs S&P 500 (13W)-35.61%

Net Margin Growth (5Y)5.31%

Dividend Yield (TTM)1.24%

Beta0.79x

P/FCF (Annual)16.60x

Revenue / Share (TTM)$38.00

ROE (TTM)24.41%

52-Week Low$190.38

vGradeB

gGradeB

mGradeD

vgmGradeC

Show chart for

Earnings Surprise History

Q3 262.86est. 2.82

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

3.72

3.68

3.69

Industry Peers — Surgical & Medical Instruments(138)

Symbol	Value Score	Growth Score	Momentum Score	Price
RMDResMed Inc.	B	B	D	$186.44
SYKStryker Corporation	C	C	D	$299.46
MMM3M Company	C	F	C	$150.93
BSXBoston Scientific Corp.	C	B	F	$47.98
MDLNMedline Inc. Class A common stock	C	D	D	$35.75
BDXBecton, Dickinson and Co.	B	C	C	$145.33
DXCMDexCom, Inc.	C	B	C	$74.87
WSTWest Pharmaceutical Services, Inc.	D	C	B	$316.30
SOLVSolventum Corporation	C	D	C	$75.84
PENPenumbra, Inc.	F	C	C	$318.95
GMEDGLOBUS MEDICAL INC	B	A	C	$79.78

About

ResMed is a global leader in respiratory care devices for sleep apnea treatment, with structural growth tailwinds from rising diagnoses, aging populations, and increasing obesity prevalence. The company generates approximately two-thirds of revenue from the Americas, with the remainder from Europe, Japan, and Australia. ResMed is building competitive differentiation through digital health platforms that deliver clinical data to patients, healthcare providers, and payers in out-of-hospital settings.